Literature DB >> 7627691

Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia.

D Gaffney1, J M Reid, I M Cameron, K Vass, M J Caslake, J Shepherd, C J Packard.   

Abstract

The apoB arginine-to glutamine change at codon 3500 has become established as a cause of failure of binding of the LDL particle to its receptor and the consequent hypercholesterolemia of familial defective apoB 100. A search for further similar mutations was undertaken by systematic screening of a candidate region of the apoB gene from individuals with hypercholesterolemia. Polymerase chain reaction and denaturing gradient gel electrophoresis were used. We describe two families in which a different mutation in the codon 3500 causes an arginine-to-tryptophan substitution. Most adults in these families who have this mutation have hypercholesterolemia. LDL derived from all who have inherited the mutation is dysfunctional in that it allows only poor growth of an LDL cholesterol-dependent cell line. We conclude that this arginine 3500 is essential to the function of apoB and that its loss and replacement by glutamine or tryptophan is responsible for the hypercholesterolemia of familial defective apoB 100.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627691     DOI: 10.1161/01.atv.15.8.1025

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

1.  Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.

Authors:  J Boren; I Lee; W Zhu; K Arnold; S Taylor; T L Innerarity
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

2.  Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations.

Authors:  M Chmara; B Wasag; M Zuk; J Kubalska; A Wegrzyn; M Bednarska-Makaruk; E Pronicka; H Wehr; J C Defesche; A Rynkiewicz; J Limon
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

3.  Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia.

Authors:  Christopher T Johansen; Jian Wang; Matthew B Lanktree; Henian Cao; Adam D McIntyre; Matthew R Ban; Rebecca A Martins; Brooke A Kennedy; Reina G Hassell; Maartje E Visser; Stephen M Schwartz; Benjamin F Voight; Roberto Elosua; Veikko Salomaa; Christopher J O'Donnell; Geesje M Dallinga-Thie; Sonia S Anand; Salim Yusuf; Murray W Huff; Sekar Kathiresan; Robert A Hegele
Journal:  Nat Genet       Date:  2010-07-25       Impact factor: 38.330

Review 4.  Susceptibility mutations for ischemic heart disease.

Authors:  B G Nordestgaard; A Tybjaerg-Hansen
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.113

5.  Molecular characterization of Iranian patients with possible familial hypercholesterolemia.

Authors:  E Farrokhi; F Shayesteh; S Asadi Mobarakeh; F Roghani Dehkordi; K Ghatreh Samani; M Hashemzadeh Chaleshtori
Journal:  Indian J Clin Biochem       Date:  2011-02-10

6.  Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene.

Authors:  Mariame El Messal; Karima Aït Chihab; Rachid Chater; Joan Carles Vallvé; Faïza Bennis; Aïcha Hafidi; Josep Ribalta; Mathilde Varret; Mohammed Loutfi; Jean Pierre Rabès; Anass Kettani; Catherine Boileau; Luis Masana; Ahmed Adlouni
Journal:  J Hum Genet       Date:  2003-03-18       Impact factor: 3.172

7.  Common and rare gene variants affecting plasma LDL cholesterol.

Authors:  John R Burnett; Amanda J Hooper
Journal:  Clin Biochem Rev       Date:  2008-02

Review 8.  Recent advances in molecular genetics of cardiovascular disorders. Implications for atherosclerosis and diseases of cellular lipid metabolism.

Authors:  G Schmitz; C Aslanidis; K J Lackner
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

9.  Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.

Authors:  René Wintjens; Dominique Bozon; Khaldia Belabbas; Félicien MBou; Jean-Philippe Girardet; Patrick Tounian; Mathilde Jolly; Franck Boccara; Ariel Cohen; Alexandra Karsenty; Béatrice Dubern; Jean-Claude Carel; Ahlam Azar-Kolakez; François Feillet; François Labarthe; Anne-Marie Colin Gorsky; Alice Horovitz; Catherine Tamarindi; Pierre Kieffer; Anne Lienhardt; Olivier Lascols; Mathilde Di Filippo; Fabienne Dufernez
Journal:  J Lipid Res       Date:  2016-01-22       Impact factor: 5.922

10.  Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity.

Authors:  Alexis C Frazier-Wood; Ani Manichaikul; Stella Aslibekyan; Ingrid B Borecki; David C Goff; Paul N Hopkins; Chao-Qiang Lai; Jose M Ordovas; Wendy S Post; Stephen S Rich; Michèle M Sale; David Siscovick; Robert J Straka; Hemant K Tiwari; Michael Y Tsai; Jerome I Rotter; Donna K Arnett
Journal:  Hum Genet       Date:  2012-12-22       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.